Search
Elaine Darby says the capital will accelerate the company's programs.

AusCann raises $33m for cannabis development

Joondalup-based medicinal cannabis hopeful AusCann Holdings has secured $33.4 million from local and North American institutions, with NYSE-listed marijuana play Canopy Growth Corporation upping its stake to 11.2 per cent.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Share Price

Closing price for the last 90 trading days
Powered by Morningstar ®

BN30 Index

Index = 100 as of 4 Jan 2016
Source: Morningstar

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Powered by Morningstar ®

Total Shareholder Return as at 31/03/20

1 year TSR5 year TSR
202ndNeuroScientific Biopharmaceuticals6%
352ndKatana Capital-19%-5%
565thAusCann Group Holdings-49%38%
669 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

04/03/20
$21k Bought
08/03/19
$11k Bought
07/03/19
$47k Bought
Total value as at the date of the transaction
Powered by Morningstar ®

Revenue

151st↑AusCann Group Holdings$671k
173rd-NeuroScientific Biopharmaceuticals$34k
174th↓Katana Capital$2.2m
176th↑Cervantes Corporation$76k
177th↓Pura Vida Energy$74k
198 listed industrial companies ranked by revenue.
Powered by Morningstar ®